Financial News
Articles published by Omeros Corporation
Omeros Corporation Reports Third Quarter 2022 Financial Results
November 09, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Receives Decision from FDA on Formal Dispute Resolution Request for Narsoplimab
November 08, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2022
November 04, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Announces Royalty Monetization Transaction with DRI Healthcare Trust
October 03, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
September 15, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Receives Interim Response from FDA on Formal Dispute Resolution Request for Narsoplimab
August 17, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Reports Second Quarter 2022 Financial Results
August 09, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 1, 2022
February 24, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA
January 19, 2022
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
December 23, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Reports Third Quarter 2021 Financial Results
November 09, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
November 05, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021
November 04, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA
October 01, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Corporation Reports Second Quarter 2021 Financial Results
August 09, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction
June 10, 2021
From Omeros Corporation
Via Business Wire
Tickers
OMER
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.